Captopril and hydrochlorotiazide
Company: Mylan LaboratoriesApproval Status: Approved May 1997
Treatment for: hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology
Possible similar drugs: Captopril and hydrochlorotiazide
General Information
Captopril and hydrochlorothiazide tablets have been tentatively approved for the treatment of hypertension. Tablets will be manufactured in 25mg/15mg, 50mg/15mg, 25mg/25mg and 50mg/25mg strengths. This antihypertensive product is the generic equivalent of Bristol-Myers Squibb?s capozide. Shipment is scheduled to begin after the Dec. 27, 1997 expiration of Bristol-Myers Squibb?s patent.
Captopril and hydrochlorotiazide Drug Information
The Captopril And Hydrochlorotiazide drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
